q1medicare.com
Powered by Q1Group LLC
A non-government resource for the Medicare community
Powered by Q1Group LLC
A non-government Medicare community resource
  • Menu ☰
  • Home
  • Contact
  • MAPD
  • PDP
  • 2024
  • 2025
  • FAQs
  • Articles
  • Search ⌕
  • Contact
  • 2024
  • 2025
  • FAQs
  • Articles
  • Latest Medicare News
  • Search ⌕

February 2023 Medicare Drug List Updates: Seventy-one (71) medications added to the 2023 Medicare Part D Drug plan formularies.

Category: Monthly Formulary Changes
Published: Feb, 28 2023 03:02:18
< Previous
Next >
The February 2023 Medicare Part D prescription drug plan formulary (drug list) data is now online and included in our Formulary Browser and Q1Rx Drug Finder.

The February formulary updates include the addition of 103 new National Drug Codes (NDCs), representing 71 different prescription drugs, many with multiple strengths.

The formulary updates impact both stand-alone Medicare Part D plans (PDPs) and Medicare Advantage plans with drug coverage (MAPDs).


Highlights of the February 2023 Formulary updates include sixteen (16) newly-introduced brand-name drugs

The February drug data updates include thirty-three (33) new brand-name drugs, sixteen (16) of which are newly introduced brand-name drugs, some with multiple strengths. These drugs include:
  • ADLARITY®,
  • CAPLYTA®,
  • CRESEMBA®,
  • DESCOVY®,
  • ENTADFI®,
  • HYFTOR®,
  • JYNNEOS®,
  • OSMOLEX ER®,
  • PHEBURANE®,
  • RELEUKO®,
  • RELYVRIO®,
  • RYALTRIS®,
  • SOTYKTU®,
  • VIVJOA®,
  • VTAMA®, and
  • ZONISADE.

The February 2023 Formulary updates include sixteen (16) newly-added generic drugs

The February Medicare Part D drug data also includes thirty-eight (38) new generic medications, sixteen (16) of which are newly-introduced generic drugs.  These new generic drugs include:
  • APEXICON [Apexicon E®],
  • DABIGATRAN ETEXILATE [Pradaxa®],
  • FINGOLIMOD [Gilenya®],
  • FINZALA [Minastrin®],
  • INSULIN DEGLUDEC [Tresiba®],
  • JAVYGTOR [KUVAN®],
  • LEVAMLODIPINE [CONJUPRI®],
  • MESALAMINE [Pentasa®],
  • NAPROXEN [Naprelan®],
  • NORETH-EE-FE [Tri-Legest Fe®],
  • PENCICLOVIR [Denavir®],
  • PIRFENIDONE,
  • POTASSIUM CL [K-Tab®],
  • ROFLUMILAST [Daliresp®],
  • TAFLUPROST [ZIOPTAN®], and
  • VENLAFAXINE BESYLATE.

Please note that these new generic and brand-name drugs are not available on all Medicare Part D or Medicare Advantage drug plans - and you can review the chart to see the (often limited) number of plan formularies that now include these drugs.


Reminders about Medicare prescription drug plan formulary changes
  1. Medicare Part D plans (PDPs and MAPDs) can change their formulary or drug list during the year and may drop one of your formulary medication mid-year for specific Medicare-allowable reasons (such as a new generic drug is available), but there are steps you can take if your medication is no longer covered by your prescription drug plan.

  2. In most cases, your Medicare Part D plan will notify you if the plan drops a medication you are currently using.

Good to know: What is the NDC?

The NDC or National Drug Code is used to uniquely identify a particular drug, manufacturer, strength, and packaging combination. The NDC is often shown on your prescription bottle as an 11-digit code (see the charts below) or could be formatted as 00000-0000-00 where the first set of numbers identifies the drug manufacturer, the second set of number identifies the product and strength, and the third set of numbers identifies the packaging.  You can read more here: Q1FAQ.com/155


Summary of February 2023 NDC changes

There are many reasons for NDCs to be added to the Medicare Part D program, a summary for all 103 new February 2023 NDCs is as follows:

Reason for NDC Addition Occurrences
New Delivery Form 3
New Delivery Form and Strength 2
New Drug 30
New Drug and Strength 36
New Manufacturer 1
New Manufacturer and Delivery Form 1
New Manufacturer and Strength 13
New Manufacturer, Strength and Delivery Form 1
New Strength 16
Grand Total 103

The following chart details the 103 new manufacturer / drug-strength / packaging combinations (NDCs) that were added to one or more Medicare Part D formularies in the most recent updates -- as you will notices, some drugs are only covered by a few Medicare plans.

You can click on the Drug Name below to go to our Q1Medicare.com Drug Finder (Q1Rx.com) and see the details of how this drug is covered by all Medicare Part D plans (PDPs) in Florida (our example state).  You can then change the state in our search form for details of drug coverage in your service area.


NDC Drug Name Number of
PDP Formularies*		 Number of
MAPD Formularies*		 Notes
72143025130 ACCUTANE 10 MG CAPSULE [ZENATANE] 52 352 New Strength
72143025230 ACCUTANE 20 MG CAPSULE [ZENATANE] 52 353 New Strength
65038005603 ADLARITY 10MG/DAY WEEKLY PATCH 5 16 New Drug and Strength
65038005503 ADLARITY 5 MG/DAY WEEKLY PATCH 5 16 New Drug and Strength
76204001055 ALBUTEROL SUL 0.63 MG/3 ML SOLUTION VIAL-NEB [Accuneb] 58 391 New Drug and Strength
76204001155 ALBUTEROL SUL 1.25 MG/3 ML SOLUTION VIAL-NEB [Accuneb] 58 391 New Drug and Strength
62559036530 APEXICON E 0.05% CREAM (G) [Apexicon E] 1 18 New Drug
00069781030 CADUET 10 MG-10 MG TABLET 0 2 New Strength
00310351260 CALQUENCE 100 MG TABLET 58 376 New Delivery Form
72060011040 CAPLYTA 10.5 MG CAPSULE 62 391 New Strength
72060012140 CAPLYTA 21 MG CAPSULE 62 391 New Strength
51672412301 CARBAMAZEPINE ER 100 MG TABLET 12H [Tegretol -XR] 62 391 New Drug and Strength
51672412401 CARBAMAZEPINE ER 200 MG TABLET 12H [Tegretol -XR] 62 391 New Drug and Strength
51672412501 CARBAMAZEPINE ER 400 MG TABLET 12H [Tegretol -XR] 62 391 New Drug and Strength
00254200501 CHLORZOXAZONE 750 MG TABLET [Lorzone] 0 20 New Manufacturer and Strength
69784038313 COREG CR 10 MG CAPSULE CPMP 24HR 1 2 New Drug and Strength
69784038513 COREG CR 20 MG CAPSULE CPMP 24HR 1 2 New Drug and Strength
69784038713 COREG CR 40 MG CAPSULE CPMP 24HR 1 2 New Drug and Strength
69784038813 COREG CR 80 MG CAPSULE CPMP 24HR 1 2 New Drug and Strength
00469052002 CRESEMBA 186 MG CAPSULE 25 93 New Drug
63323066910 KCL 20 MEQ/L IN D5W IV SOLUTION 54 315 New Manufacturer and Strength
67877047560 DABIGATRAN ETEXILATE 150 MG CP CAPSULE [Pradaxa] 50 242 New Drug and Strength
67877047460 DABIGATRAN ETEXILATE 75 CAPSULE [Pradaxa] 50 242 New Drug and Strength
61958200501 DESCOVY 120-15 MG TABLET 62 391 New Strength
49884014811 DEXLANSOPRAZOLE DR 60 MG CAPSULE DR BP [Kapidex] 17 83 New Manufacturer and Strength
68025006530 DIVIGEL 0.25 MG GEL PACKET 25 68 New Strength
68025006630 DIVIGEL 0.5 MG GEL PACKET 25 68 New Strength
68025008330 DIVIGEL 0.75 MG GEL PACKET 25 68 New Strength
68025008630 DIVIGEL 1.25 MG GEL PACKET 25 68 New Strength
00310090060 DUAKLIR PRESSAIR 400-12MCG INH AER POW BA 0 6 New Drug
24478010201 DYANAVEL XR 2.5 MG/ML SUSP BP 24H 0 5 New Delivery Form and Strength
69681012530 ENTADFI 5-5 MG CAPSULE 0 29 New Drug
00378452593 FINGOLIMOD 0.5 MG CAPSULE [Gilenya] 49 375 New Drug
00093821028 FINZALA 1-0.02(24)-75 CHEWABLE TABLET [Minastrin] 9 99 New Drug
73683010110 HYFTOR 0.2% GEL 7 89 New Drug
00480012649 ICOSAPENT ETHYL 500 MG CAPSULE [VASCEPA] 31 159 New Manufacturer and Strength
57962000712 IMBRUVICA 70 MG/ML ORAL SUSPENSION 62 391 New Delivery Form
73070040011 INSULIN DEGLUDEC 100 UNIT/ML VIAL [Tresiba] 0 11 New Drug and Strength
73070040315 INSULIN DEGLUDEC PEN (U-100) INSULN PEN [Tresiba] 0 11 New Drug and Strength
73070050315 INSULIN DEGLUDEC PEN (U-200) INSULN PEN [Tresiba] 0 11 New Drug and Strength
43598009730 JAVYGTOR 100 MG POWDER PACKET [KUVAN] 35 209 New Drug and Strength
43598009604 JAVYGTOR 100 MG TABLET SOL [KUVAN] 40 261 New Drug and Strength
43598016230 JAVYGTOR 500 MG POWDER PACKET [KUVAN] 35 210 New Drug and Strength
50632000102 JYNNEOS 0.5 ML VIAL(STOCKPILE) 18 200 New Drug
00276050410 KETOPROFEN 25 MG CAPSULE [Orudis] 2 47 New Drug and Strength
00276050610 KETOPROFEN 50 MG CAPSULE [Orudis] 3 58 New Drug and Strength
43598051663 LENALIDOMIDE 2.5 MG CAPSULE [Revlimid] 62 385 New Manufacturer and Strength
43598051421 LENALIDOMIDE 20 MG CAPSULE [Revlimid] 62 385 New Manufacturer and Strength
42195042530 LEVAMLODIPINE 2.5 MG TABLET [CONJUPRI] 0 5 New Drug and Strength
42195045030 LEVAMLODIPINE MALEATE 5 MG TABLET [CONJUPRI] 0 5 New Drug and Strength
70257041487 LYVISPAH 10 MG GRANULE PACKET 0 3 New Strength
70257041287 LYVISPAH 5 MG GRANULE PACKET 0 3 New Strength
00078092525 MAXIDEX 0.1% EYE DROPS EYE DROPPER 1 63 New Drug
00078110515 MEKINIST 0.5 MG TABLET 62 391 New Strength
43975026403 MEMANTINE HCL ER 14 MG CAPSULE SPR 24 [Namenda XR] 50 369 New Manufacturer and Strength
43975024303 MEMANTINE HCL ER 21 MG CAPSULE SPR 24 [Namenda XR] 50 369 New Manufacturer and Strength
43975024203 MEMANTINE HCL ER 7 MG CAPSULE SPR 24 [Namenda XR] 50 371 New Manufacturer and Strength
63304008913 MESALAMINE ER 500 MG CAPSULE ER [Pentasa] 21 111 New Drug
00276051010 METHOCARBAMOL 1,000 MG TABLET 0 11 New Drug
59746000314 METHYLPREDNISOLONE 16 MG TABLET [Medrol Dosepak] 62 391 New Drug
25021013182 METRONIDAZOLE 500 MG/100 ML PIGGYBACK [Flagyl RTU] 62 391 New Drug
67877043630 MINOCYCLINE ER 55 MG TABLET 24H [Solodyn] 0 8 New Drug
00480095101 NAPROXEN SOD ER 375 MG TABLET TBMP 24HR [Naprelan] 0 22 New Drug and Strength
00480095258 NAPROXEN SOD ER 500 MG TABLET TBMP 24HR [Naprelan] 0 21 New Drug and Strength
00378730353 NORETH-EE-FE 1 MG/20-30-35 MCG TABLET [Tri-Legest Fe] 44 284 New Drug
00085222402 NOXAFIL 300 MG POWDERMIX SUSPDR PACKET 5 134 New Delivery Form and Strength
75834011250 OFLOXACIN 400 MG TABLET [Floxin] 26 211 New Strength
51167012201 ORKAMBI 75-94 MG GRANULE PACK 52 371 New Strength
70482007530 OSMOLEX ER 129 MG TABLET BP 24H 4 75 New Strength
82154044901 PEGASYS 180 MCG/ML VIAL 60 388 New Drug and Strength
82154045104 PEGASYS 180 MCG/0.5 ML SYRINGE 62 391 New Drug and Strength
00378089655 PENCICLOVIR 1% CREAM (G) [Denavir] 8 102 New Drug
71770020010 PHEBURANE PELLET GRANULES 1 54 New Drug
42385092590 PIRFENIDONE 534 MG TABLET 31 277 New Drug
63323068310 POTASSIUM CL 20 MEQ-0.45% NACL IV SOLUTION 53 350 New Manufacturer and Strength
63323068610 POTASSIUM CL 20 MEQ/1,000ML-NS IV SOLUTION 33 280 New Manufacturer and Strength
63323068810 POTASSIUM CL 40 MEQ/1,000ML-NS IV SOLUTION 29 269 New Manufacturer and Strength
70436015301 POTASSIUM CL ER 20 MEQ TABLET [K-Tab] 62 391 New Drug
50742033630 PRAMIPEXOLE ER 3.75 MG TABLET 24H [Mirapex ER] 5 119 New Manufacturer and Strength
70121156801 RELEUKO 300 MCG/0.5 ML SYRINGE 1 66 New Drug and Strength
70121157001 RELEUKO 480 MCG/0.8 ML SYRINGE 1 66 New Drug and Strength
73063003503 RELYVRIO 3 GM-1 GM POWDER PACKET 1 43 New Drug
31722062330 ROFLUMILAST 500 MCG TABLET [Daliresp] 62 390 New Drug
59467070027 RYALTRIS 665-25 MCG SPRAY/PUMP 3 11 New Drug
72000032010 SIVEXTRO 200 MG VIAL 37 223 New Delivery Form
00003089511 SOTYKTU 6 MG TABLET 0 15 New Drug
81968035101 SUNOSI 150 MG TABLET 1 143 New Drug and Strength
81968035001 SUNOSI 75 MG TABLET 1 143 New Drug and Strength
42571026473 TAFLUPROST 0.0015% EYE DROP DROPERETTE [ZIOPTAN] 1 66 New Drug
00713080531 TAZAROTENE 0.05% GEL [TAZORAC] 41 195 New Manufacturer, Strength and Delivery Form
00713080431 TAZAROTENE 0.1% GEL [TAZORAC] 41 195 New Manufacturer and Delivery Form
55150022810 TIGECYCLINE 50 MG VIAL [Tygacil] 54 363 New Drug
50742028760 TIMOLOL MALEATE 0.25% EYE DROP DROPERETTE [Timoptic Ocumeter] 4 81 New Manufacturer
70954054110 TRIMETHOPRIM 100 MG TABLET [Proloprim] 62 391 New Drug
80725000601 VALIUM 10 MG TABLET 0 2 New Drug and Strength
80725000401 VALIUM 2 MG TABLET 0 2 New Drug and Strength
80725000501 VALIUM 5 MG TABLET 0 2 New Drug and Strength
52427063230 VENLAFAXINE BESYLATE ER 112.5 MG TABLET 24H 42 190 New Drug and Strength
68001049604 VENLAFAXINE HCL ER 37.5 MG TABLET 24H 1 97 New Drug and Strength
62559038530 VEREGEN 15% OINTMENT 0 16 New Drug
74695082318 VIVJOA 150 MG CAPSULE 3 26 New Drug
81672505101 VTAMA 1% CREAM (G) 0 13 New Drug
52652800101 ZONISADE 100 MG/5 ML ORAL SUSPENSION 62 390 New Drug




Our online Formulary Browser and Drug Finder

You can review any Medicare plan formulary using the Q1Medicare.com Formulary Browser found at: FormularyBrowser.com or compare how any medication is covered on all Medicare plans in your Service Area using our Drug Finder found at: Q1Rx.com.

Additional Formulary Drug Change Articles:

Medicare Part D Plan Formulary (Drug Lists) Updates:
September 2023, August 2023, June 2023, May 2023, April 2023, March 2023, February 2023, August 2022, June 2022, May 2022, April 2022, March 2022, February 2022, August 2021, June 2021, May 2021, April 2021, September 2020, August 2020, June 2020, May 2020, April 2020, March 2020, September 2019, July 2019, June 2019, May 2019, April 2019, March 2019, August 2018, July 2018, June 2018, May 2018, April 2018, August 2017, July 2017, May 2017, April 2017, August 2016, July 2016, June 2016, April 2016, March 2016, October 2015, August 2015, July 2015, May 2015, April 2015, August 2014, May 2014, August 2013, June 2013, May 2013, April 2013, August 2012, July 2012, June 2012

Formulary Changes to the Top Medicare Drugs:
September 2023, September 2022, September 2021, September 2020, April 2020, September 2019, April 2019, August 2018, April 2018, August 2017, April 2017, August 2016, April 2016, October 2015, April 2015, August 2014, August 2013, April 2013

New Generic Equivalents Added to Formularies:
June 2023, February 2023, August 2021, June 2021, May 2021, April 2021, September 2020, August 2020, June 2020, May 2020, April 2020, March 2020, September 2019, July 2019, June 2019, May 2019, April 2019, March 2019, August 2018, July 2018, April 2018, August 2017, July 2017, April 2017, March & April 2016, April & May 2015, August 2014, May 2014


News Home
< Previous   Next >




Medicare Supplements
fill the gaps in your
Original Medicare
1. Enter Your ZIP Code:
» Medicare Supplement FAQs


News Categories
Selecting Your Medicare Plan
Star Ratings & Plan Quality
Annual Medicare Plan Changes
Enrollment Topics
Late Enrollment Penalty
Your Formulary (Drug List)
Monthly Formulary Changes
Your Medicare Plan Coverage
Pharmacies & Providers
Changing Medicare Plans
Special Enrollment Periods SEP
The Donut Hole or Coverage Gap
Donut Hole Discounts
Straddle Claims and High Costs
Out of Pocket: TrOOP and MOOP
Medicaid, LIS, & Extra Help
IRMAA - for Higher Incomes
Medicare Advantage Plans MAPD
Medicare Supplements - Medigap
Medicare Plan Providers
Marketing Medicare Products
General Medicare Part D PDP
General Medicare
Diabetes and Diabetic Coverage
Your Health & Wellness
About Q1Medicare.com




© Q1Group LLC 2005 - 2024  



Tips & Disclaimers
  • Q1Medicare®, Q1Rx®, and Q1Group® are registered Service Marks of Q1Group LLC and may not be used in any advertising, publicity, or for commercial purposes without the express authorization of Q1Group.
  • The Medicare Advantage and Medicare Part D prescription drug plan data on our site comes directly from Medicare and is subject to change.
  • Medicare has neither reviewed nor endorsed the information on our site.
  • We provide our Q1Medicare.com site for educational purposes and strive to present unbiased and accurate information. However, Q1Medicare is not intended as a substitute for your lawyer, doctor, healthcare provider, financial advisor, or pharmacist. For more information on your Medicare coverage, please be sure to seek legal, medical, pharmaceutical, or financial advice from a licensed professional or telephone Medicare at 1-800-633-4227.
  • We are an independent education, research, and technology company. We are not affiliated with any Medicare plan, plan carrier, healthcare provider, or insurance company. We are not compensated for Medicare plan enrollments. We do not sell leads or share your personal information.
  • Benefits, formulary, pharmacy network, provider network, premium and/or co-payments/co-insurance may change on January 1 of each year. Our PDPCompare.com and MACompare.com provide highlights of annual plan benefit changes.
  • The benefit information provided is a brief summary, not a complete description of benefits. For more information contact the plan.
  • Limitations, copayments, and restrictions may apply.
  • We make every effort to show all available Medicare Part D or Medicare Advantage plans in your service area. However, since our data is provided by Medicare, it is possible that this may not be a complete listing of plans available in your service area. For a complete listing please contact 1-800-MEDICARE (TTY users should call 1-877-486-2048), 24 hours a day/7 days a week or consult www.medicare.gov.
    Statement required by Medicare:
    "We do not offer every plan available in your area. Any information we provide is limited to those plans we do offer in your area. Please contact Medicare.gov or 1-800-MEDICARE to get information on all of your options."
  • When enrolling in a Medicare Advantage plan, you must continue to pay your Medicare Part B premium.
  • Medicare beneficiaries with higher incomes may be required to pay both a Medicare Part B and Medicare Part D Income Related Monthly Adjustment Amount (IRMAA). Read more on IRMAA.
  • Medicare Advantage plans that include prescription drug coverage (MAPDs) are considered Medicare Part D plans and members with higher incomes may be subject to the Medicare Part D Income Related Monthly Adjustment Amount (IRMAA), just as members in stand-alone Part D plans. In certain situations, you can appeal IRMAA.
  • You must be enrolled in both Medicare Part A and Part B to enroll in a Medicare Advantage plan. Members may enroll in a Medicare Advantage plan only during specific times of the year. Contact the Medicare plan for more information.
  • If you are enrolled in a Medicare plan with Part D prescription drug coverage, you may be eligible for financial Extra Help to assist with the payment of your prescription drug premiums and drug purchases. To see if you qualify for Extra Help, call: 1-800-MEDICARE (1-800-633-4227). TTY users should call 1-877-486-2048, 24 hours a day/ 7 days a week or consult www.medicare.gov; the Social Security Office at 1-800-772-1213 between 7 a.m. and 7 p.m., Monday through Friday. TTY users should call, 1-800-325-0778; or your state Medicaid Office.
  • Medicare evaluates plans based on a 5-Star rating system. Star Ratings are calculated each year and may change from one year to the next.
  • A Medicare Advantage Private Fee-for-Service plan (PFFS) is not a Medicare supplement plan. Providers who do not contract with the plan are not required to see you except in an emergency.
  • Disclaimer for Institutional Special Needs Plan (SNP): This plan is available to anyone with Medicare who meets the Skilled Nursing Facility (SNF) level of care and resides in a nursing home.
  • Disclaimer for Dual Eligible (Medicare/Medicaid) Special Needs Plan (SNP): This plan is available to anyone who has both Medical Assistance from the State and Medicare. Premiums, co-pays, co-insurance, and deductibles may vary based on the level of Extra Help you receive. Please contact the plan for further details.
  • Disclaimer for Chronic Condition Special Needs Plan (SNP): This plan is available to anyone with Medicare who has been diagnosed with the plan specific Chronic Condition.
  • Medicare MSA Plans combine a high deductible Medicare Advantage Plan and a trust or custodial savings account (as defined and/or approved by the IRS). The plan deposits money from Medicare into the account. You can use this money to pay for your health care costs, but only Medicare-covered expenses count toward your deductible. The amount deposited is usually less than your deductible amount, so you generally have to pay out-of-pocket before your coverage begins.
  • Medicare MSA Plans do not cover prescription drugs. If you join a Medicare MSA Plan, you can also join any separate (stand-alone) Medicare Part D prescription drug plan
  • There are additional restrictions to join an MSA plan, and enrollment is generally for a full calendar year unless you meet certain exceptions. Those who disenroll during the calendar year will owe a portion of the account deposit back to the plan. Contact the plan provider for additional information.
  • Medicare beneficiaries may enroll through the CMS Medicare Online Enrollment Center located at www.medicare.gov.
  • Medicare beneficiaries can file a complaint with the Centers for Medicare & Medicaid Services by calling 1-800-MEDICARE 24 hours a day/7 days or using the medicare.gov site. Beneficiaries can appoint a representative by submitting CMS Form-1696.
.